Skip to main content
OpenTrials

Clinical trial condition

Urological Manifestations

Explore clinical trials studying Urological Manifestations. Study availability and eligibility vary by location and protocol.

2,297 public trials 272 recruiting studies
Refine in advanced search Browse all conditions

Urological Manifestations trial results

Completed

A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH

NCT02264639

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +18 more
Locations
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Lakes Research Miami Lakes, Florida, United States
  • University of Lousiville Louisville, Kentucky, United States
  • John Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Completed

InterStim® Amplitude Study

NCT03335761

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Academic Urology & Urogynecology of Arizona Phoenix, Arizona, United States
  • East Coast Institute for Research Jacksonville, Florida, United States
  • Pinellas Urology St. Petersburg, Florida, United States
  • Florida Urology Partners Tampa, Florida, United States
View all 18 locations
View Trial Details
Completed

Mirabegron For Erectile Dysfunction

NCT02916693

Conditions
Erectile Dysfunction, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
Locations
  • Johns Hopkins Medical Institutions Baltimore, Maryland, United States
View Trial Details
Completed

Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years

NCT02757963

Conditions
Genital Diseases, Genital Diseases, Male, Lower Urinary Tract Symptoms, +7 more
Locations
  • GSK Investigational Site Aigrefeuille-sur-Maine, France
  • GSK Investigational Site Grenay, France
  • GSK Investigational Site Haute-Goulaine, France
  • GSK Investigational Site La Montagne, France
View all 45 locations
View Trial Details
Completed

Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder

NCT02820844

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Chiba, Japan
  • GSK Investigational Site Chiba, Japan
View all 48 locations
View Trial Details

Related conditions